{"anticipatedPostingDate":"2028-02","denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"From the time the informed consent form is signed up to 30 days after last dose","title":"Number of Participants With Treatment-emergent Adverse Events After Administration of Valemetostat Tosylate Monotherapy (Cohort 1)","type":"SECONDARY"}